71 related articles for article (PubMed ID: 18686048)
1. Serum interleukin-33 and soluble suppression of tumorigenicity 2 in pediatric leukemia with febrile neutropenia.
Polat MC; Sönmez Ç; Yarali N; Özbek NY
Eur J Pediatr; 2024 May; 183(5):2155-2162. PubMed ID: 38367066
[TBL] [Abstract][Full Text] [Related]
2. Can C-reactive protein be used as a surrogate marker of IL-6 in a broad array of clinical entities?
Ali SB; Cecchin A; Lucchesi C; Putty T; Edwards S; Petrou T; Coates P; Ferrante A; Pucar PA; King J; Banovic T
Biomark Med; 2023 Dec; 17(24):1001-1010. PubMed ID: 38235562
[No Abstract] [Full Text] [Related]
3. Outcome of severe infections in afebrile neutropenic cancer patients.
Strojnik K; Mahkovic-Hergouth K; Novakovic BJ; Seruga B
Radiol Oncol; 2016 Dec; 50(4):442-448. PubMed ID: 27904453
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis.
Evans CA; Jellis J; Hughes SP; Remick DG; Friedland JS
J Infect Dis; 1998 Jun; 177(6):1582-7. PubMed ID: 9607836
[TBL] [Abstract][Full Text] [Related]
5. Periodontal inflamed surface area in oral cavity associated with febrile neutropenia in patients with hematologic malignancy undergoing chemotherapy.
Nishi H; Ohta K; Kuramoto Y; Shigeishi H; Obayashi T; Yoshioka Y; Konishi M; Munenaga S; Nagoshi H; Yoshida T; Fukushima N; Kakimoto N; Ohge H; Kurihara H; Ichinohe T; Kawaguchi H
Sci Rep; 2022 Feb; 12(1):2483. PubMed ID: 35169215
[TBL] [Abstract][Full Text] [Related]
6. Pro-inflammatory cytokine ratios determine the clinical course of febrile neutropenia in children receiving chemotherapy.
Siegmund M; Pagel J; Scholz T; Rupp J; Härtel C; Lauten M
Mol Cell Pediatr; 2020 Jun; 7(1):5. PubMed ID: 32519027
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).
Heinz WJ; Buchheidt D; Christopeit M; von Lilienfeld-Toal M; Cornely OA; Einsele H; Karthaus M; Link H; Mahlberg R; Neumann S; Ostermann H; Penack O; Ruhnke M; Sandherr M; Schiel X; Vehreschild JJ; Weissinger F; Maschmeyer G
Ann Hematol; 2017 Nov; 96(11):1775-1792. PubMed ID: 28856437
[TBL] [Abstract][Full Text] [Related]
8. Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation.
Döring M; Cabanillas Stanchi KM; Mezger M; Erbacher A; Feucht J; Pfeiffer M; Lang P; Handgretinger R; Müller I
BMC Cancer; 2015 Aug; 15():607. PubMed ID: 26315105
[TBL] [Abstract][Full Text] [Related]
9. Biomarker candidates for the detection of an infectious etiology of febrile neutropenia.
Richter ME; Neugebauer S; Engelmann F; Hagel S; Ludewig K; La Rosée P; Sayer HG; Hochhaus A; von Lilienfeld-Toal M; Bretschneider T; Pausch C; Engel C; Brunkhorst FM; Kiehntopf M
Infection; 2016 Apr; 44(2):175-86. PubMed ID: 26275448
[TBL] [Abstract][Full Text] [Related]
10. Intensive serial biomarker profiling for the prediction of neutropenic Fever in patients with hematologic malignancies undergoing chemotherapy: a pilot study.
Chan SM; Chadwick J; Young DL; Holmes E; Gotlib J
Hematol Rep; 2014 Apr; 6(2):5466. PubMed ID: 25013718
[TBL] [Abstract][Full Text] [Related]
11. Use of inflammatory molecules to predict the occurrence of fever in onco-hematological patients with neutropenia.
Ribeiro AF; Nobre V; Neuenschwander LC; Teixeira AL; Xavier SG; Paula FD; Teixeira MM; Teixeira JC; Bittencourt H
Braz J Med Biol Res; 2013 Feb; 46(2):200-6. PubMed ID: 23369970
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of procalcitonin and eight additional inflammatory molecules in febrile neutropenic patients.
Neuenschwander LC; Bittencourt H; Ribeiro AF; Teixeira AL; Teixeira MM; Teixeira JC; Nobre V
Clinics (Sao Paulo); 2011; 66(10):1699-705. PubMed ID: 22012040
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein in critically ill cancer patients with sepsis: influence of neutropenia.
Póvoa P; Souza-Dantas VC; Soares M; Salluh JF
Crit Care; 2011; 15(3):R129. PubMed ID: 21595932
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma thioredoxin levels in patients with sepsis: positive association with macrophage migration inhibitory factor.
Leaver SK; MacCallum NS; Pingle V; Hacking MB; Quinlan GJ; Evans TW; Burke-Gaffney A
Intensive Care Med; 2010 Feb; 36(2):336-41. PubMed ID: 19756498
[TBL] [Abstract][Full Text] [Related]
15. Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients.
Buyukberber N; Buyukberber S; Sevinc A; Camci C
Med Oncol; 2009; 26(1):55-61. PubMed ID: 18686048
[TBL] [Abstract][Full Text] [Related]
16. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.
Engel A; Mack E; Kern P; Kern WV
Infection; 1998; 26(4):213-21. PubMed ID: 9717678
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of IL-1 beta, sIL-2R, IL-6, IL-8, and TNF-alpha in febrile children with cancer and neutropenia.
Soker M; Colpan L; Ece A; Devecioğlu C; Haspolat K
Med Oncol; 2001; 18(1):51-7. PubMed ID: 11778970
[TBL] [Abstract][Full Text] [Related]
18. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia.
Lehrnbecher T; Venzon D; de Haas M; Chanock SJ; Kühl J
Clin Infect Dis; 1999 Aug; 29(2):414-9. PubMed ID: 10476751
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
